Tiziana Life Sciences’ Post

Interesting insights and learnings from Theresa. Learn more about people and culture 👍

Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies

Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies

The first quarter of 2024 witnessed mergers and acquisitions positively shaping the industry's trajectory. These deals reflect the current trend in Big Pharma: snapping up small late-stage biotechs. In parallel, the IPO market showcased more promise, underscoring the industry's resilience and investors' confidence in innovative biotech ventures. Read more in Fierce Biotech: https://bit.ly/3Ja42Si #MergersAndAcquisitions #PharmaceuticalIndustry #Innovation #Healthcare #IPOs

Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies

Many of today’s most lucrative medicines might not have become so without mergers and acquisitions. And while 2021 and 2022 were much quieter for dealmaking, there are signs of a rebound. Check out this database from BioPharma Dive, which is tracking the latest M&A activity, and dates back to 2018: https://hubs.la/Q02mQfF40 #M&A #Biopharma

𝗜𝘁’𝘀 𝗴𝗼𝗼𝗱 𝘁𝗼 𝗯𝗲 𝗯𝗮𝗰𝗸 𝗮𝘁 IESE Business School (𝗷𝘂𝘀𝘁 𝗳𝗼𝗿 𝗮 𝗰𝗼𝘂𝗽𝗹𝗲 𝗼𝗳 𝗱𝗮𝘆𝘀. 😊) Happy to be back! Even though it’s only for a moment this time. Couple of productive days with my colleague Prof. Vardit Landsman, working on (1) the commercial consequences of mergers and acquisitions and (2) measuring launch excellence in pharma. #Team #LaunchExcellence #Pharma #Academia #IESE #IESEBusinessSchool, Julian Villanueva Galobart, Carlos Garcia-Pont, Jorge Gonzalez

5 Strategies to Expand Your Pharma Company 1. Research and Development (R&D) Investment 2. Market Diversification 3. Strategic Partnerships 4. Mergers and Acquisitions (M&A) 5. Digital Transformation The pharma industry is competitive, expensive, and constantly evolving, requiring leaders to embrace multiple approaches to form a well-rounded expansion plan. The key to making your expansion plan successful is analyzing trends, building a solid internal team and tailoring each strategy to fit the unique needs of your pharma company. #pharma #strategic_partnership #market_diversification #licensing https://lnkd.in/duKz2Fij

Pharma and life sciences are witnessing increased collaboration and partnership deals to address strategic gaps and foster innovation Read the full article: 2024 Outlook for Pharma Mergers and Acquisitions ▸ https://lttr.ai/ANCXs #mergers #acquistions #jpm2024 #pharma #biotech

We are pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May.   May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights.   #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies